How Generative AI Streamlines GxP Compliance In Life Sciences

By Kathleen Brunner, President & CEO, Acumen Analytics

Generative AI is reaching a critical juncture in the life sciences industry. This type of AI, which encompasses natural language processing (NLP) and natural language generation (NLG), goes beyond conventional data analysis and report creation by automating complex processes and producing new content, data, insights, and predictions from the information they have been given. As a result, it enables organizations to improve operational efficiency, allowing them to concentrate on their primary goal of delivering safer, more effective treatments to market at an accelerated pace.